G. Hardavella (Athens, Greece), I. Rousalova (Prague, Czech Republic), K. Skaug (Haugesund, Norway), R. Mroz (Bialystok, Poland)
LATE-BREAKING ABSTRACT: Expression of macrophage migration inhibitory factor (MIF) in the serum and lung tissues in patients with non-small cell lung cancer (NSCLC)
Y. Luo, J. Zhang, H. Liao, Z. Li, C. Xie, Y. Guo (Guangzhou, China)
|  |
Clinical implication of stem cell markers in N2 positive non-small cell lung cancer
B.Y. Lee, M.A. Kim, J.C. Lee, Y.S. Park, H.R. Kim, C.M. Choi (Seoul, Republic Of Korea)
|  |
Association of XPD and CDA polymorphisms with clinical outcome in non-small cell lung cancer in a Chinese population
M. Zhou, Y. Ding, H. Wan (Shanghai, China)
| |
The metallopeptidase neprilysin is a hypoxia-induced prognostic factor in lung adenocarcinoma
K. Leithner, C. Wohlkoenig, E. Stacher, J. Lindenmann, N.A. Hofmann, B. Ebner, F. Quehenberger, F.M. Smolle-Jüttner, S. Philipsen, H.H. Popper, A. Hrzenjak, A. Olschewski, H. Olschewski (Graz, Austria; Rotterdam, Netherlands)
| |
Prognostic value of ERCC1 expression in advanced non-small cell lung cancer (NSCLC)
J. Kollmeier, T. Blum, D. Misch, A. Roth, C. Boch, W. Gruening, C. Crolow, S. Griff, T. Mairinger, T. T. Bauer (Berlin, Germany)
| |
EGFR exon in lung cancer: Survival predictors?
I. Ladeira, A. Antunes, C. Ribeiro, A. Barroso, S. Conde, B. Parente (Vila Nova de Gaia, Portugal)
| |
Prognostic value of fluorine-18 fluorodeoxyglucose (18-FDG) positron emission tomography imaging in patients with non-small cell lung carcinoma
A. S. Yurdakul, F. Yildirim, S. Özkaya, U. O. Akdemir, C. Öztürk (Ankara, Izmir, Turkey)
| |
EpCAM-positive circulating cells in lung cancer patients
J. Domagala-Kulawik, T. Skirecki, G. Hoser (Warsaw, Poland)
| |
Independent prognostic und predictive value of blood vessel invasion (BVI) in curatively (R0) resected stage II and IIIA non-small cell lung (NSCLC) cancer patients
D. Wuerflein, W. M. Brueckl, D. Kraus, C. Meyer, M. Wagner, J. H. Ficker (Nuremberg, Germany)
| |
Impacts of multi and specific co-morbidities on the survival of non-surgical non-small cell lung cancer
K.S. Yu, L.A. Tse, I.T.S. Yu, M.C.S. Wong, S.K.J. Au, J.S.Y. Chor (Hong Kong, China)
| |
High mRNA expressions of KLF2 improve post operative prognosis of pulmonary adenocarcinoma correlation with chemokine receptor CCR7 and genetical mutations of p53
M. Itakura, Y. Terashima, M. Shingyouji, T. Iizasa, H. Kimura (Chiba City, Bunkyo-ku, Japan)
| |
Prognostic impact of nestin expression in resected large cell neuroendocrine carcinoma of the lung
S. Ryuge, Y. Sato, S. X. Jiang, T. Matsumoto, K. Katono, S. Igawa, M. Yokoba, J. Sasaki, A. Iyoda, M. Katagiri, Y. Satoh, N. Masuda (Sagamihara, Japan)
| |
The impact of neuroendocrine differentiation in the prognosis of non-small cell lung cancer
A. Charpidou, C. Fevranoglou, T. Sotirios, B. Paraskevi, M. Zontanos, I. Danos, K. Syrigos (Athens, Greece)
| |
Long-term outcomes and prognostic factors for neuroendocrine G1 and G2 lung tumors
J. Wälscher, G. Weinreich, D. Theegarten, S. Ting, A. Tannapfel, G. Stamatis (Essen, Bochum, Germany)
| |
The increase of circulating B7-H4-expressing CD68+ macrophage correlated with clinical stage of lung carcinomas
J.A. Huang, C. Chen, Y. Zhu, X. Zhang (Suzhou, China)
| |
Prognostic value of SUVmax in patients with lung cancer who underwent surgical treatment
D. Alves, J. Cruz, C. Pacheco, B. Fernandes, J. Cunha (Braga, Portugal)
| |
Outcomes of NSCLC patients with positive EGFR mutation
S. Diver, M. Haris, S. Leyakathali khan, J. Kerr, J. Edwards, M. Munavvar (Preston, United Kingdom)
| |
One year survival differences of EGFR- and KRAS-mutated advanced non-small cell lung cancer (NSCLC) compared to the wildtype population
C. Boch, J. Kollmeier, A. Roth, D. Misch, A. Streubel, T. Mairinger, T. T. Bauer (Berlin, Germany)
| |
Recruitment of podoplanin positive cancer-associated fibroblasts in metastatic lymph nodes predicts poor prognosis in pathological N2 stage III lung adenocarcinoma
S. Neri, G. Ishii, K. Aokage, T. Hishida, J. Yoshida, K. Nagai, A. Ochiai (Kashiwa, Japan)
| |
Immunohistochemical expression of Bcl-2 and p53 in patients with lung cancer: Correlation with survival time
B. Ilievska Poposka, S. Smickoska, G. Petrusevska (Skopje, Fyrom)
| |